November 1, 2016 – Oxygen Therapy, Inc., the developer of innovative oxygen therapies for treating and protecting the brain during and after stroke, announced that it has filed a registration statement on Form S-1 with the Securities and Exchange Commission.

Oxygen Therapy, Inc. Files S-1 Registration Statement